LQDA
$36.35+6.50%
Liquidia CorporationStock · HealthcareRussell 2000 · 0.2% of IWMNasdaq Composite · 0.01% of ONEQUS Stock Market · 0.008% of VTIRussell 3000 · 0.007% of IWV
LQDA — Liquidia Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEEEEE
10.020.030.040.050.060.070.080.090.0050.0M$36.35—20182020202220242026
2026-10-20
Price$36.35
MA20$67.41
MA50$49.69
Vol39.8M
Key stats#
Price data
- Price
- $36.35
- YTD price return
- +5.39%
- YTD total return
- +5.39%
- Next earnings
- Nov 2, 2026
- Market cap
- 3.3B
- Enterprise value
- 3B
- Shares outstanding
- 89.5M
- 52W low
- $21.94
- 52W high
- $93.61
- From 52W high
- -61.17%
- From 52W low
- +65.68%
- 52W range
- 20%
Volume
- Rel volume
- 0.75×
- 30D volume
- 5.1M
- 30D $ vol
- 177.4M
Fundamentals
- Sales (ttm)
- 450.9M
- Sales/share
- $5.04
- EPS (ttm)
- $1.47
- FCF (ttm)
- 150.7M
- FCF/share
- $1.68
- Book value/share
- $2.18
- Net margin
- 30.74%
- ROE
- 71.04%
- ROA
- 26.56%
- Current ratio
- 2.31
Growth (CAGR, ttm) · 10Y
- Sales
- +2238.69%+193.60%+128.77%n/a
- Shares
- +3.97%+11.40%+11.49%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +2149.34%+163.55%+105.20%n/a
- Book value/share
- +1137.66%+32.50%+7.47%n/a
- Price
- +48.77%+80.58%+58.89%n/a
- Total return
- +48.77%+80.58%+58.89%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 24.7×
- Fwd P/E
- 15.7×
- P/S (ttm)
- 7.2×
- P/B (mrq)
- 16.7×
- P/FCF (ttm)
- 21.6×
- EV/EBITDA (fy)
- 17.5×
- EV/Sales (ttm)
- 6.6×
- FCF yield (ttm)
- 4.63%
- Buyback yield (realized, 1y)
- -3.97%
- Shareholder yield (realized, 1y)
- -3.97%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 4th
- P/B
- 74th
Bar = where today’s multiple sits in LQDA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+6.50%
5D
+35.58%
1M
-45.65%
3M
-52.84%
YTD
+5.39%
1Y
+48.73%
5Y
+912.53%
Financial statements
Open full LQDA financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
